Daniel Ortiz

Daniel Ortiz has a diverse and extensive work experience spanning several roles and companies. Daniel is currently working as the Senior Director of Research at Inozyme Pharma since April 2022. Before this, they were the Director at The Janssen Pharmaceutical Companies of Johnson & Johnson from October 2020 to March 2022.

Prior to their role at Janssen, Ortiz worked at Momenta Pharmaceuticals, where they held multiple positions. Daniel served as the Director of Research from June 2020 to September 2020, the Associate Director of Research from February 2018 to June 2020, the Principal Scientist from January 2015 to January 2018, and the Senior Scientist from June 2013 to December 2014.

Ortiz also worked at Momenta Pharmaceutical in two separate periods. Daniel was the Associate Director from November 2018 to June 2020 and the Principal Scientist from January 2015 to January 2018.

Before their industry experience, Ortiz had an extensive research career at Tufts University School of Medicine. Daniel worked as a Research Assistant Professor from January 1996 to November 2011 and as a Research Associate from January 1993 to January 1996. During this time, they focused on molecular biology, physiology, cellular biology, protein biochemistry, and genetics. Daniel also obtained independent funding and developed expertise in various research techniques.

Additionally, Ortiz worked as a Research Geneticist at the Gene Expression Center UC/USDA from January 1990 to January 1993. Their research focused on identifying and cloning yeast genes essential for heavy metal tolerance, obtaining independent funding, and making significant contributions to the field.

Overall, Daniel Ortiz's work experience showcases their expertise in research and leadership roles within the pharmaceutical industry and academia.

Daniel Ortiz earned a Bachelor of Sciences in Biology from the University of Costa Rica in 1983. Following this, they pursued a Doctor of Philosophy degree in Molecular studies at the University of Georgia Graduate School of Arts and Sciences, completing it by 1990.